Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression

By D. Harnois. 2010

644 citations recorded by the source corpus.

Subfields: Epidemiology, Hepatology, Pathology and Forensic Medicine

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. H. B. EL‐SERAG
2. F. Kanwal
3. E. Gower
4. K. Razavi-Shearer
5. C. Estes
6. S. Blach
7. Riccardo Lencioni
8. H. Razavi

In Hepatology

1. H. B. EL‐SERAG
2. E. Gower
3. T. de Baère
4. K. Razavi-Shearer
5. Michael C. Soulen
6. C. Estes
7. W. Rilling
8. F. Kanwal

In Pathology and Forensic Medicine

1. T. de Baère
2. H. B. EL‐SERAG
3. W. Rilling
4. F. Kanwal
5. Riccardo Lencioni

Citations in the corpus

• Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data (2016, background): “Unlike most solid cancers, future incidence and mortality rates for HCC were projected to largely increase in several regions around the world over the next several years, mostly as a result of the dissemination of hepatitis C virus infection.((2,3)) Despite the widespread implementation of surveill”
• Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. (2012, neutral): “Pegylated interferon monotherapy 14/530 (3) 4/125 (3) 10/405 (2) .”
• Epidemiology of Hepatocellular Carcinoma in the United States: Where Are We? Where Do We Go? (2014, background): “general population of HCV-infected individuals estimated that the number of HCC cases increased from 37,697 between 1990 and 1999 to 86,765 (1130%) between 2000 and 2009, with a projected increase to 130,366 (150%) cases between 2010 and 2019.(54) We found similar time trends in the prevalence of HC”
• Global epidemiology and genotype distribution of the hepatitis C virus infection. (2014, background): “In fact, other studies have suggested that HCV prevalence may be declining with time in some countries [28,29,56,57].”